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Abstract
Aims To investigate the renal effects of fitness in people with diabetes with mild renal dysfunction.
Methods The effect of a 12-week exercise programme on estimated GFR in 128 people with diabetes was evaluated.
Results All cardiometabolic variables improved after 12 weeks of supervised exercise. Although there was a modest
3.9% increase in estimated GFR from baseline in the 128 people who completed the study, those with baseline chronic
kidney disease stages 2 and 3 were found to have significant (6 and 12%, respectively; p < 0.01) improvements in post-
exercise estimated GFR. Moreover, 42% of the people with chronic kidney disease stage 3 improved to chronic kidney
disease stage 2 after the intervention.
Conclusion Short-term exercise improves renal function in those with more moderate baseline chronic kidney disease.
Thus, renal function appears to be responsive to enhanced physical fitness. Being a strong and modifiable risk factor,
enhanced fitness should be considered a non-pharmacological adjunct in the management of diabetic kidney disease.
Diabet. Med. 32, 1342–1345 (2015)
Introduction
Diabetes is the leading cause of chronic kidney disease and
progression to end-stage renal disease, and estimated GFR
(eGFR) is an independent predictor of death and cardiovas-
cular events [1]. Approximately 40% of people with diabetes
will develop chronic kidney disease. The vast majority of these
people will have mild to moderate stages of chronic kidney
disease based on eGFR (i.e. stages 1–3) [2], although they will
also be significantly susceptible to cardiovascular disease [3].
Despite multifactorial diabetes treatment methods, the rate of
chronic kidney disease is rising and end-stage renal disease
rates continue to show a poor response to these treatments [4].
Cardiorespiratory fitness, as measured by exercise capac-
ity, is a modifiable risk factor and a strong predictor of
mortality in chronic illnesses, including Type 2 diabetes
[5,6]. Although physical activity is the essential component
for improving cardiorespiratory fitness [7], people with
chronic kidney disease are known to have reduced physical
function, low physical activity, increased muscle wasting and
consequently have diminished exercise capacity [8]. Con-
flicting results, however, have been reported with regard to
the role of exercise training in chronic kidney disease [9–12],
which is perhaps related to the predominance of people with
end-stage renal disease in interventional studies [13]. Despite
the paucity of information on the milder stages of chronic
kidney disease, eGFR correlates with physical activity and
exercise capacity and can therefore serve as a guide to renal
responsiveness [14].
The aim of the present study was to correlate exercise
capacity to eGFR in response to a short-term interventional
exercise programme in people with Type 2 diabetes.
Methods
Exercise cohort
A total of 128 people with Type 2 diabetes were enrolled in a
supervised exercise programme for 12 weeks. The exclusion
criteria included failure to pass an exercise tolerance test, a
major illness in the last 6 months (myocardial infarction,
congestive heart failure, stroke, pneumonia or acute kidney
disease) or HbA1c level > 9% ( > 75 mmol/mol).
Exercise programme
After providing signed consent, the patients were given
comprehensive nutritional and physical activity guidance.
The biweekly exercise sessions were supervised by a trained
exercise physiologist and consisted of a 1-h session thatCorrespondence to: Eric Nylen. E-mail: enylen@gmail.com
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included warm-up and cool-down and 30 min of combined
aerobic and resistance training at an exercise intensity of 50–
80% of heart rate reserve. The patients were also encouraged
to be physically active during the rest of the week. Baseline
and post-exercise data included BMI, systolic and diastolic
blood pressure (mmHg), HbA1c (mmol/mol and %), creat-
inine (lmol/l) and urinary albuminuria (mg/g creatinine).
Capillary glucose was obtained before and immediately after
each exercise session. Diabetes and other medication adjust-
ments were unchanged during the 12-week period, unless
clinically indicated.
Statistical analysis
The pre- and post-exercise responses were analysed using the
paired t-statistic. All 128 patients participated in a minimum
of 15 supervised sessions for 12 consecutive weeks. All
hypotheses were two-sided and P values < 0.05 were taken
to indicate statistical significance. All statistical analyses were
performed using SPSS software version 22.0 (SPSS Inc.).
Results
A total of 128 people with Type 2 diabetes were recruited
and completed the exercise programme. The majority were
black (79%) and male (95%), and their mean  SD age was
62  2.1 years. The change in eGFR from baseline using the
‘CKD-EPI’ formula [15] in the entire cohort was 3.9%
(mean  sd eGFR at baseline: 76.1  21.9 ml/min/1.73 m2;
after exercise programme: 79.1  19.7 ml/min/1.73 m2).
The patients were then classified into three groups based
on baseline eGFR: group 1 included patients with
eGFR > 89 ml/min/1.73 m2 (n = 38), group 2 included
patients with eGFR 60–89 ml/min/1.73 m2 (n = 53) and
group 3 included patients with chronic kidney disease
stage 3 with eGFR 30–59 ml/min/1.73 m2 (n = 37). Those
with chronic kidney disease stage 3 were slightly older
(age 63.8  7.2 years compared with 62.0  2.1 and
62.5  7.4 years in the groups with chronic kidney disease
stages 1 and 2, respectively) and had a longer duration of
diabetes (8.9  9.2 years compared with 7.5  2.8 and
5.9  6.8 years in the groups with chronic kidney disease
1 and 2, respectively). Exercise for 12 weeks resulted in
improved trends in all cardiometabolic variables as shown
in Table 1. Notably, there was a significant improvement in
metabolic equivalents in all three groups (P < 0.001); HbA1c
levels were significantly lower in those with chronic kidney
disease stages 1 and 3 (P < 0.001); and plasma glucose levels
were significantly improved in the chronic kidney disease
stage 1 group (P = 0.001). After the exercise programme,
there was no significant change in eGFR in those with
chronic kidney disease stage 1. By contrast, for patients in the
chronic kidney disease stages 2 and 3 groups, there was a
significant and gradual improvement in eGFR (improvements
of 6 and 12%, respectively; P = 0.003 and P = 0.0007).
Interestingly, 42% of the people with chronic kidney disease
stage 3 improved to chronic kidney disease 1 or 2 (n = 16)
after the intervention.
Discussion
The present study shows that renal function is responsive to
the level of fitness as measured by exercise capacity. As
kidney function plays a central role in diabetes morbidity and
mortality, these results may be of clinical significance.
The present study showed that supervised physical activity
for 12 weeks had a positive impact on all cardiometabolic
variables including renal function. More specifically, a
significant improvement in eGFR was seen in those patients
with a compromised baseline renal function, i.e. those with
chronic kidney disease stages 2 and 3; 42% of the latter
group reverted to chronic kidney disease stage 1 or 2.
Exercise had less of an impact, therefore, in those with a
normal baseline eGFR, which could reflect the inaccuracy of
Table 1 Cardiometabolic response to exercise
Chronic kidney disease stage 1
(n = 38)
Chronic kidney disease stage 2
(n = 53)
Chronic kidney disease stage 3
(n = 37)
Before exercise After exercise Before exercise After exercise Before exercise After exercise
METs 8.7  2 10.2  2.4* 8.4  0.3 10.0  2.4* 6.9  1.6 8.4  2.3*
Weight, kg 101.3  16.7 99.6  14.0 101.7  16.5 99.4  14.5 102.7  17.2 101.7  17.0
Systolic blood pressure 121.4  14.6 116.1  13.8 124.4  15.4 121.2  14.4 128  15 124  14
Diastolic blood pressure 71.4  9.6 68.1  9.7 72.9  9.8 70.8  11.4 71  8 69  8
HbA1c, mmol/mol 61  16 52  10* 62  19 57  14 66  21 56  13*
HbA1c, % 7.7  1.5 6.9  0.9* 7.8  1.7 7.4  1.3 8.2  1.9 7.3  1.2*
Glucose, mmol/l 7.65  2.7 6.43  1.7* 8.05  2.9 7.10  2.1 8.05  3.1 7.49  3.8
Creatinine, lmol/l 70.9  15.3 67.9  9.2 86.2  16.0 86.9  19.1 114.4  25.9 106.8  28.2
UAE†, mg/g 40.5  87 32.9  81 22.6  36 16.7  21 46.8  35 31.8  22
eGFR, ml/min/1.73 m2 103.6  11.2 100.6  13.1 73.5  6.9 78.3  13.1 51.6  8.7 58  13.2
METs, metabolic equivalents; UAE, urinary albumin excretion.
*P < 0.05.
†Median and interquartile range (quartile 1 to 3).
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the formula for eGFR in those with closer to normal renal
function, and/or the fact that these patients need a higher
exercise dose to show a change.
We believe these results to be clinically relevant because
exercise is a non-invasive and non-pharmaceutical treatment
method that can be performed and adapted at an individual
level. Indeed, the cumulative exercise dose in the present
interventional study was less than the recommended
150 min/week [16]. Potentially, a similar amount of exercise
could help those patients with progressive kidney disease not
only to improve their kidney function but also to possibly
prevent or delay the need for dialysis in the long term. As
fitness is a modifiable risk factor in most patients, an
appropriate exercise programme could be implemented for
people at high risk of developing chronic kidney disease to
prevent or at least attenuate the rate of progression. Indeed,
a recent meta-analysis supports a multitude of benefits from
physical activity of > 30 min/session for 3 days per week in
patients with chronic kidney disease [11] although the
majority of studies have been in those with more advanced
stages of chronic kidney disease, including those receiving
dialysis or who have undergone transplants [11–13]. To
date, little research has been conducted in the majority of
patients who have the pre-dialysis range of chronic kidney
disease stages and who have significant cardiovascular
disease risk [3] and the highest potential for comorbidity
modulation. Moreover, there is a lack of exercise promotion
in these patients [17]. Aerobic exercise in patients at the pre-
dialysis stage has been shown to increase exercise capacity
significantly, as measured by peak oxygen consumption
(VO2 max) [9], exercise tolerance [9] and anaerobic threshold
[9]. Moreover, in one study, there was a significant
improvement in eGFR after 12 weeks of aerobic exercise
in overweight patients with chronic kidney disease stages 3
and 4 [18].
The response of increased exercise capacity supports the
likelihood that causal mechanism(s) may exist. The salutary
response to exercise may be related to several factors.
People with diabetes are known to exercise significantly less
than the general population, and this is most likely
compounded in those with diabetes and chronic kidney
disease. Patients with chronic kidney disease have a 50–
80% reduction in exercise capacity [19], a high degree of
inactivity, muscle wasting, reduced muscle function and
muscle weakness [10,11]. Other causal factors could be
related to the kidney disease itself, such as endothelial
dysfunction, oxidative stress, inflammation and dyslipida-
emia [20]; for example, regular exercise affects structural
and functional adaptations of the endothelial response to
vasoconstrictors and vasodilators and exercise also has anti-
inflammatory effects.
Strengths of the present study include its supervised
exercise approach, which enhances individual guidance and
compliance. Its limitations include not knowing the precise
cause of chronic kidney disease and limitations inherent to
the eGFR calculation; we used the CKD-EPI formula,
considered by many to be the optimum method [15].
In summary, we show that a short-term interventional
exercise programme improved eGFR in those with mild to
moderate chronic kidney disease (stages 2 and 3). Because a
moderate intensity exercise programme was effective in
improving fitness, we suggest that exercise interventions for
individuals at risk of chronic kidney disease and those with
pre-clinical chronic kidney disease merit scrutiny in a
randomized trial.
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